在 中文 中使用 非小细胞肺癌 的示例及其翻译为 英语
{-}
-
Political
-
Ecclesiastic
-
Programming
ROS1基因的重排发生在1-2％的非小细胞肺癌（NSCLC）中。
ROS1 gene fusions account for 1-2% of non-small-cell lung cancer(NSCLC).CD39和CD73在肿瘤中表达升高与胃肠道、妇科和非小细胞肺癌患者的预后不良有关。
Increased expression of CD39 and CD73 in tumors is associated with poor prognosis in patients with gastrointestinal, gynaecological, and non-small cell lung cancer.ROS1融合基因大约出现在1-2%的非小细胞肺癌（NSCLC），….
ROS1 gene fusions account for 1-2% of non-small-cell lung cancer(NSCLC).但是，结果并非是得到一份健康清单--非小细胞肺癌在她的右肺中复发了。
But instead of leaving with a clean bill of health, she learned the non-small cell lung cancer had returned in her right 一项最新研究详细介绍了血液检测的发展通过血液检测可以在72小时内识别与非小细胞肺癌（NSCLC）相关的基因突变。
A new study details the development of a blood test that can identify genetic mutations associated with non-small cell lung cancer within 72 hours.非小细胞肺癌手术手术去除癌症（通常与其他治疗方法）可能是早期非小细胞肺癌（NSCLC）的选择。
Surgery to remove the cancer(often along with other treatments) may be an option for early stage non-small cell lung cancer(NSCLC).一项新的研究详细介绍了在72小时内可以鉴定与非小细胞肺癌相关基因突变的血液检测的发展。
New research details the development of a blood test that can identify genetic mutations associated with non-small cell lung cancer within 72 hours.这项研究于4月4日在“柳叶刀肿瘤学”杂志上发表，重点介绍非小细胞肺癌，这是最常见的肺癌形式。
The study, published April 4 in the journal The Lancet Oncology, focused on non-small cell lung cancer, which is the most.在三种主要的非小细胞肺癌的被命名为在肿瘤细胞的类型：.
The three main kinds of non small cell lung cancer are named for the type of 每种类型的非小细胞肺癌都有不同种类的癌细胞。
In non small cell lung cancer, each type of cancerous 在三种主要的非小细胞肺癌的被命名为在肿瘤细胞的类型：.
The three main types of nonsmall cell lung cancer are named for the type of 约有四分之一的美国非小细胞肺癌患者患有III期疾病，估计会影响超过43,000名患者。
Stage III 我们的目标是让我们1/4的非小细胞肺癌患者都接受靶向治疗。
It is our goal to treat a quarter of our patients with non-small cell lung cancer 年8月，吉非替尼首先作为非小细胞肺癌一线治疗药物在日本上市，商品名为易瑞沙。
In August 2002, gefitinib, as a first-line treatment of non-small cell lung cancer drugs, was first listed in Japan under the trade name 在中国，晚期非小细胞肺癌最常见的突变就是EGFR,ALK。
The most important driver mutations in non-small lung cancer are EGFR and ALK.部分样本来自非小细胞肺癌患者；另一些则来自健康对照组。
Some samples came from patients with non-small cell lung cancer while others were drawn from healthy controls.以上的非小细胞肺癌（NSCLC）患者确诊时年龄超过65岁。
More than 65% of patients diagnosed with non-small cell lung cancer(NSCLC) are above the age of 65 years.大约有三分之一的非小细胞肺癌患者在诊断时已进入第三阶段。
Approximately one-third of patients with non-small cell lung cancer have advanced stage 3 disease at the time of diagnosis.这种突变在3-5%的非小细胞肺癌的人群中发生。
This mutation is present in three to five percent of people with non-small cell lung cancer.在约10-20%非小细胞肺癌(NSCLC)存在这类突变。
Such mutations are present in approximately 10-20 percent of non-small cell lung cancers(NSCLC).
